Join Cecelia Koetting, OD, FAAO, Dipl ABO, on this month's episode of The MOD Pod as she learns about how imaging and biomarkers can be used to diagnose, manage, and treat ocular and systemic conditions (aka oculomics) from Modern Optometry contributor Shane Kannarr, OD. Dr. Koetting's second guest is Nabila Gomez, OD, FAAO, who explains how intense-pulsed light therapy can be an excellent treatment option for patients with ocular rosacea.
-------- Â
37:50
COLLAB CORNER - Patient Communication Strategies
Walt Whitley, OD, MBA, FAAO, joins Marc R. Bloomenstein, OD, FAAO, to discuss patient communication strategies. The two share techniques for how to educate patients about their conditions, treatment options, and management by being direct and relatable. They also stress the value of making it a team effort with the patient when it comes to improving their condition.
-------- Â
17:31
EMPOWER - Corneal Health and the Relevance of Specialty Lenses
Staying ahead in patient care and business growth requires the right knowledge and tools. In the first installment of the EMPOWER: Business + Optometric Specialty Care series, Jacob Lang, OD, FAAO; Diana Chu, OD; and Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, explore the critical role of corneal health and how specialty lenses can transform patient outcomes.
-------- Â
31:11
Sleep + DED • Motivating Staff
This month on The MOD Pod, host Cecelia Koetting, OD, FAAO, Dipl ABO, welcomes guests Josh Davidson, OD, FAAO, FSLS, and Marlon Monelyon-Demeritt, OD, MBA, FAAO. Dr. Koetting and Dr. Davidson discuss the relationship between sleep and risk level of dry eye disease, with Dr. Davidson citing studies that support this connection. Dr. Monelyon-Demeritt shares simple and effective ways to keep staff engaged.
-------- Â
39:40
The Near Future in Managing Dry Eye Disease
Cecelia Koetting, OD, FAAO, DipABO, and Marc Bloomenstein, OD, FAAO, convened to discuss the current state of ocular surface disease, including the progressive nature, patient communication and symptoms, new and upcoming therapies, and more.